Selank: GABAergic System Modulation and Enkephalinase Inhibition – A Preclinical Mechanistic Overview
Selank is a synthetic heptapeptide investigated in preclinical studies for its interactions with the GABAergic neurotransmitter system. This overview examines two proposed molecular mechanisms: GABA-A receptor gene expression modulation and enkephalin-degrading enzyme inhibition, drawing on peer-reviewed research. For research use only.
